British Journal of Ophthalmology 2007;91:1099
Copyright © 2007 by the BMJ Publishing Group Ltd.
BJO at a glance
Creig Hoyt, Editor
| The first 150 words of the full text of this article appear below. |
COMPLICATIONS OF INTRAVITREAL TRIAMCINOLONE
The use of intravitreal triamcinolone in ophthalmology continues to increase. A number of indications for its use have now been documented. One of the significant side effects of it is non-infectious endophthalmitis. Maia and coworkers in a retrospective study document that this complication (non-infectious endophthalmitis) was significantly more likely to occur when triamcinolone was used with preservatives than without. They suggest that triamcinolone should be used without preservatives.
See pages 1099 and 1122
RETINAL THICKNESS CHANGES IN DIABETES MELLITUS
Ophthalmologists are well aware of the vascular changes that occur in the retina as the result of diabetes. Recently evidence has accumulated that damage to neural and glial cells may occur in the retina even in the absence of significant retinopathy. Verbraak and coworkers measured the retinal thickness in a group of diabetic patients with minimal retinopathy. Paracentral retinal thickness was significantly decreased in these patients suggesting that intraretinal neural tissue loss is an early stage of diabetic ocular pathology.
See . . . [Full text of this article]
Relevant Articles
-
Another Anglo-American editorship
- Creig Hoyt and Andrew Dick
Br. J. Ophthalmol. 2007 91: 1099.
[Extract]
[Full Text]
[PDF]
-
A "throttle" mechanism in the central retinal vein in the region of the lamina cribrosa
- Tom H Williamson
Br. J. Ophthalmol. 2007 91: 1190-1193.
[Abstract]
[Full Text]
[PDF]
-
Decreased optical coherence tomography-measured pericentral retinal thickness in patients with diabetes mellitus type 1 with minimal diabetic retinopathy
- Carine Biallosterski, Mirjam E J van Velthoven, Robert P J Michels, Reinier O Schlingemann, J Hans DeVries, and Frank D Verbraak
Br. J. Ophthalmol. 2007 91: 1135-1138.
[Abstract]
[Full Text]
[PDF]
-
Matrix metalloproteinases in human choroidal neovascular membranes excised following verteporfin photodynamic therapy
- Olcay Tatar, Annemarie Adam, Kei Shinoda, Tillmann Eckert, Gábor B Scharioth, Micheal Klein, Efdal Yoeruek, Karl Ulrich Bartz-Schmidt, and Salvatore Grisanti
Br. J. Ophthalmol. 2007 91: 1183-1189.
[Abstract]
[Full Text]
[PDF]
-
Effects of intravitreal triamcinolone acetonide injection with and without preservative
- Mauricio Maia, Michel Eid Farah, Rubens N Belfort, Fernando Marcondes Penha, Acácio A S Lima Filho, Fabio Bom Aggio, and Rubens Belfort, Jr
Br. J. Ophthalmol. 2007 91: 1122-1124.
[Abstract]
[Full Text]
[PDF]
-
Topographic optic disc analysis by Heidelberg retinal tomography in ocular Behçet’s disease
- Nilufer Berker, Ufuk Elgin, Pinar Ozdal, Aygen Batman, Emel Soykan, and Seyhan S Ozkan
Br. J. Ophthalmol. 2007 91: 1199-1201.
[Abstract]
[Full Text]
[PDF]
-
Ranibizumab (Lucentis) versus bevacizumab (Avastin): modelling cost effectiveness
- James Raftery, Andrew Clegg, Jeremy Jones, Seng Chuen Tan, and Andrew Lotery
Br. J. Ophthalmol. 2007 91: 1244-1246.
[Abstract]
[Full Text]
[PDF]
-
Diagnostic approaches for oculoglandular tularemia: advantages of PCR
- Todor Kantardjiev, Plamen Padeshki, and Ivan N Ivanov
Br. J. Ophthalmol. 2007 91: 1206-1208.
[Abstract]
[Full Text]
[PDF]
-
Pegaptanib and ranibizumab for neovascular age-related macular degeneration: a systematic review
- A L Takeda, J Colquitt, A J Clegg, and J Jones
Br. J. Ophthalmol. 2007 91: 1177-1182.
[Abstract]
[Full Text]
[PDF]
|
|
